Karen Brajão de Oliveira

Dr. Karen Brajão de Oliveira

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
FBFERNANDA COSTA BRANDAO BERTI
FERNANDA COSTA BRANDAO BERTI
APAna Paula Lombardi Pereira
Ana Paula Lombardi Pereira
GCGuilherme Cesar Martelossi Cebinelli
Guilherme Cesar Martelossi Cebinelli
KTKleber Paiva Trugilo
Kleber Paiva Trugilo
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira

23 May 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MBMayara Bocchi
Mayara Bocchi
NPNathália Pereira
Nathália Pereira
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira
MAMarla Amarante
Marla Amarante

23 May 2020 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
APAna Paula Lombardi Pereira
Ana Paula Lombardi Pereira
KTKleber Paiva Trugilo
Kleber Paiva Trugilo
NONádia Calvo Martins Okuyama
Nádia Calvo Martins Okuyama
MSMichelle Mota Sena
Michelle Mota Sena
JCJosé D’oLiveira Couto-Filho
José D’oLiveira Couto-Filho
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira

1 January 2018 in AIMS Allergy and Immunology
Verified
Journal Article
Open access
PDF file
FBFernanda Costa Brandão Berti
Fernanda Costa Brandão Berti
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira
It is generally well-accepted and established the IL-10-mediated protumor function in cancer, based on its immunosuppressive properties. However, new evidences from in vitro and in vivo murine models have emerged showing a potential immunostimulating activity of this cytokine, which may sustain IL-10-mediated antitumor function in cancer, hence favoring tumor regression. Here, we attempt to clarify IL-10’s role in cancer, by conducting a literature review of previously published studies, presenting information about IL-10 immunosuppressive and/or immunostimulating properties. Different and contradictory IL-10 effects leading to tumor growth (e.g., suppression of pro-inflammatory cytokines or inhibition of immune response recognition steps) or tumor regression (e.g., stimulation of cytotoxic and cytolytic activities of immune cells or inhibition of angiogenic factors) were found in distinct scenarios, hindering the establishment of a general role for IL-10 in cancer. Such definition is still a challenge, maybe due to a lack of sufficient information to support it, or perhaps based on the fact that IL-10 role in distinct cancer contexts may vary, switching from a classical immunosuppressive factor to an immunostimulating one.

1 November 2015 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira

16 January 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
LMLuis Fernando Lasaro Mangieri
Luis Fernando Lasaro Mangieri
FCFernando Cezar-Dos-Santos
Fernando Cezar-Dos-Santos
KTKleber Paiva Trugilo
Kleber Paiva Trugilo
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe
RCRafaela Roberta de Jaime Curti
Rafaela Roberta de Jaime Curti
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira
The aim of this study was to determine the incidence of infections and cytological abnormalities and to investigate possible predisposing factors such as sociodemographic characteristics, sexual behavioral habits, and gynecological and obstetric backgrounds. Between 2013 and December 2016, a cross-sectional study was conducted among 429 consenting women, from whom cervical samples were tested for the presence of Human papillomavirus (HPV) by polymerase chain reaction (PCR). Susceptibility to HPV infection was assessed by binary logistic regression in light of possible predisposing factors, which were collected using a questionnaire. In our sample population, the prevalence of HPV infection was 49%; high-risk types had a higher prevalence of 89.1%. A larger proportion of HPV-infected women were under 25 years of age, were single, and had monthly incomes up to minimum wage. Multivariate binary logistic regression analysis showed that age younger than 25 years increased the odds of infection fivefold, while a monthly income of one to three minimum wages provided protection against HPV infection, even if the women were married or had a cohabiting partner. In the HPV-positive group, squamous intraepithelial lesions (SIL) occurred more frequently in women who earned up to one minimum wage monthly, but a monthly income of one to three minimum wages protected against the development of SIL. The results suggest that age, marital status, and monthly income are important cofactors for HPV infection and the development of SIL.